70 results on '"Minai, Omar A."'
Search Results
2. Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment
3. Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials
4. Association of impaired heart rate recovery with cardiopulmonary complications after lung cancer resection surgery
5. Clinical characteristics and prediction of pulmonary hypertension in severe emphysema
6. Perioperative Risk and Management in Patients With Pulmonary Hypertension
7. Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis
8. Effect of Obesity on B-Type Natriuretic Peptide Levels in Patients With Pulmonary Arterial Hypertension
9. Comparison of Baseline Predictors of Prognosis in Pulmonary Arterial Hypertension in Patients Surviving ≤2 Years and Those Surviving ≥5 Years After Baseline Right-Sided Cardiac Catheterization
10. Lung deflation and oxygen pulse in COPD: Results from the NETT randomized trial
11. Pulmonary hypertension: An important predictor of outcomes in patients undergoing non-cardiac surgery
12. Pulmonary Hypertension in COPD: Epidemiology, Significance, and Management: Pulmonary Vascular Disease: The Global Perspective
13. Pulmonary hypertension in lung diseases: Survey of beliefs and practice patterns
14. Frequency and Impact of Pulmonary Hypertension in Patients With Obstructive Sleep Apnea Syndrome
15. Bronchogenic Carcinoma after Lung Transplantation: Characteristics and Outcomes
16. Prevalence and Characteristics of Restless Legs Syndrome in Patients With Pulmonary Hypertension
17. Vaso-active therapy can improve 6-min walk distance in patients with pulmonary hypertension and fibrotic interstitial lung disease
18. Long-term experience after transition from parenteral prostanoids to oral agents in patients with pulmonary hypertension
19. A 45-Year-Old Woman With Systemic Lupus Erythematosus and Progressive Dyspnea
20. Long-term Outcome in a Patient With Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia
21. Scedosporium apiospermum (Pseudoallescheria boydii) Infection in Lung Transplant Recipients
22. Restless Legs Syndrome in Lung Transplant Recipients
23. Lupus-associated pulmonary hypertension: Long-term response to vasoactive therapy
24. Predictors of Nocturnal Oxygen Desaturation in Pulmonary Arterial Hypertension
25. Lung Transplantation for Idiopathic Pulmonary Fibrosis
26. Pulmonary Nodules in Lung Transplant Recipients: Etiology and Outcome
27. Respiratory Failure and Sepsis Are the Major Causes of ICU Admissions and Mortality in Survivors of Lung Transplants
28. Utility of Transbronchial Needle Aspiration in the Diagnosis of Endobronchial Lesions
29. Comorbidities in end-stage lung disease
30. INFECTION CONTROL IN THE BRONCHOSCOPY SUITE: A Review
31. Scoring System for Screening of Pulmonary Hypertension in Scleroderma: The Dibosa Study
32. Measuring Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Not on Active Treatment (MOTION): A Study of the Effects of Riociguat on Patient-Reported Outcomes and an Exploration of Telemetric Technology in PAH
33. Short-term and Long-term Outcomes in Patients With Scleroderma and IPAH Undergoing Lung Transplant
34. Effect of Long-term Oral Anticoagulation in Pulmonary Arterial Hypertension (PAH)
35. Outcomes of Beta Blocker Use in Pulmonary Arterial Hypertension
36. Predictors of Outcome in Portopulmonary Hypertension
37. Physician Monitoring of Pulmonary Arterial Hypertension Subjects: Results From a Large U.S. Health Insurance Claims Database
38. Electrocardiographic Findings Before Death in Pulmonary Hypertension
39. The Correlation Between Heart Rate Recovery After 6-Minute Walk Test and FEV1 and Exercise Performance in Patient With Chronic Obstructive Airway Diseas
40. Heart Rate Recovery as a Predictor of Clinical Worsening in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Diseases
41. Causes of Death in Pulmonary Hypertension: Lessons Learned
42. Heart Rate Recovery in Patients With Pulmonary Arterial Hypertension
43. Heart Rate Recovery After 6-Minute Walk Test in Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension
44. Serial Exhaled Nitric Oxide Measurements With a Portable NO Analyzer in Healthy Obstructive Sleep Apnea Patients
45. Does Heart Rate Recovery After a Six-Minute Walk Test Correlate With Prognostic Factors in Scleroderma-Associated Pulmonary Hypertension?
46. NONCARDIAC SURGICAL OUTCOMES IN PATIENTS WITH ANGIOGRAPHICALLY PROVEN PULMONARY HYPERTENSION
47. PULMONARY HYPERTENSION IN OBESE PATIENTS: AN ANALYSIS OF HEMODYNAMIC DATA
48. PRACTICE PATTERNS REGARDING MANAGING PULMONARY HYPERTENSION IN PATIENTS WITH PARENCHYMAL LUNG DISEASES: RESULTS OF AN ACCP SURVEY
49. PULMONARY HYPERTENSION ASSOCIATED WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITOR
50. HEMODYNAMIC CHARACTERISTICS OF PULMONARY HYPERTENSION IN SLEEP APNEA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.